Cargando…
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061292/ https://www.ncbi.nlm.nih.gov/pubmed/35440692 http://dx.doi.org/10.1038/s41375-022-01570-9 |
| _version_ | 1784698699225497600 |
|---|---|
| author | Maschmeyer, Georg Bullinger, Lars Garcia-Vidal, Carolina Herbrecht, Raoul Maertens, Johan Menna, Pierantonio Pagano, Livio Thiebaut-Bertrand, Anne Calandra, Thierry |
| author_facet | Maschmeyer, Georg Bullinger, Lars Garcia-Vidal, Carolina Herbrecht, Raoul Maertens, Johan Menna, Pierantonio Pagano, Livio Thiebaut-Bertrand, Anne Calandra, Thierry |
| author_sort | Maschmeyer, Georg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9061292 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90612922022-05-04 Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) Maschmeyer, Georg Bullinger, Lars Garcia-Vidal, Carolina Herbrecht, Raoul Maertens, Johan Menna, Pierantonio Pagano, Livio Thiebaut-Bertrand, Anne Calandra, Thierry Leukemia Correction Nature Publishing Group UK 2022-04-19 2022 /pmc/articles/PMC9061292/ /pubmed/35440692 http://dx.doi.org/10.1038/s41375-022-01570-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Maschmeyer, Georg Bullinger, Lars Garcia-Vidal, Carolina Herbrecht, Raoul Maertens, Johan Menna, Pierantonio Pagano, Livio Thiebaut-Bertrand, Anne Calandra, Thierry Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title | Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title_full | Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title_fullStr | Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title_full_unstemmed | Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title_short | Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) |
| title_sort | correction: infectious complications of targeted drugs and biotherapies in acute leukemia. clinical practice guidelines by the european conference on infections in leukemia (ecil), a joint venture of the european group for blood and marrow transplantation (ebmt), the european organization for research and treatment of cancer (eortc), the international immunocompromised host society (ichs) and the european leukemia net (eln) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061292/ https://www.ncbi.nlm.nih.gov/pubmed/35440692 http://dx.doi.org/10.1038/s41375-022-01570-9 |
| work_keys_str_mv | AT maschmeyergeorg correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT bullingerlars correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT garciavidalcarolina correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT herbrechtraoul correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT maertensjohan correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT mennapierantonio correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT paganolivio correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT thiebautbertrandanne correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha AT calandrathierry correctioninfectiouscomplicationsoftargeteddrugsandbiotherapiesinacuteleukemiaclinicalpracticeguidelinesbytheeuropeanconferenceoninfectionsinleukemiaecilajointventureoftheeuropeangroupforbloodandmarrowtransplantationebmttheeuropeanorganizationforresearcha |